Document Detail

A case-control study of determinants for the occurrence of gouty arthritis in heart failure patients.
MedLine Citation:
PMID:  22723658     Owner:  NLM     Status:  Publisher    
AIMS: Gouty arthritis is a frequent and disabling complication in heart failure patients. This study aimed to investigate which factors are associated with the occurrence of gouty arthritis in these patients. METHODS AND RESULTS: A case-control study was performed in heart failure patients (February 2007 to October 2009). Cases were defined as patients with gouty arthritis. Factors that are possibly associated with gouty arthritis and/or heart failure were evaluated. Echocardiographic dimensions and laboratory values including glomerular filtration rate (GFR) and fractional excretion of uric acid (FEUA) were measured. Logistic regression analysis was used to determine crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for possibly associated factors. In total, 188 patients (59 with gouty arthritis) were included. Spironolactone use was associated with a decreased occurrence of gouty arthritis (OR 0.32, 95% CI 0.13-0.77). Independently associated with an increased occurrence of gouty arthritis were hypertensive heart failure (OR 3.6, 95% CI 1.6-8.2), New York Heart Association (NYHA) class III/IV (OR 4.5, 95% CI 1.8-11.0), lower GFR (P < 0.001), and FEUA <4% (OR 3.3, 95% CI 1.4-7.9). Among the four age/gender groups, the strongest association with gouty arthritis was found in men <65 years. CONCLUSION: Our identification of factors that are associated with the occurrence of gouty arthritis makes it possible to develop strategies to improve further the quality of life in heart failure patients. The possible decreased occurrence of gouty arthritis in spironolactone users has to be confirmed in prospective studies.
Berdine A A Hueskes; Frank F Willems; Aukelien C Leen; Patricia A Ninaber; Richard Westra; Aukje K Mantel-Teeuwisse; Hein J E M Janssens; Eloy H van de Lisdonk; Elisabeth A Roovers; Matthijs Janssen
Related Documents :
2298368 - T-cell activation in crohn's disease. increased levels of soluble interleukin-2 recepto...
6318978 - Human serum deoxythymidine-5'-triphosphatase activity as a parameter in the diagnosis a...
21350968 - The laser-pointer assisted angle reproduction test for evaluation of proprioceptive sho...
20332548 - Serum cystatin c measurement in differential diagnosis of intra and extrahepatic choles...
6271508 - Na-k-atpase in erythrocyte ghosts is not a marker for primary hypertension.
1807608 - Neural network approach to detection of metastatic melanoma from chromatographic analys...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-21
Journal Detail:
Title:  European journal of heart failure     Volume:  -     ISSN:  1879-0844     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100887595     Medline TA:  Eur J Heart Fail     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Rheumatology, Rijnstate, 6883 AZ Velp, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  BET 2: Can ultrasound be used to diagnose clavicle fractures in children?
Next Document:  Relations of circulating vitamin D concentrations with left ventricular geometry and function.